|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1997-9-11
|
|
pubmed:abstractText |
Atopic keratoconjunctivitis (AKC) is a potentially blinding disease. It is usually associated with atopic dermatitis that has been managed successfully with systemic cyclosporine A (CSA) in some severe forms of the disease. In this study, the authors evaluated systemic CSA therapy in patients with severe AKC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0161-6420
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1300-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9261317-Administration, Oral,
pubmed-meshheading:9261317-Adult,
pubmed-meshheading:9261317-Anti-Inflammatory Agents,
pubmed-meshheading:9261317-Conjunctivitis, Allergic,
pubmed-meshheading:9261317-Cyclosporine,
pubmed-meshheading:9261317-Dermatitis, Atopic,
pubmed-meshheading:9261317-Female,
pubmed-meshheading:9261317-Humans,
pubmed-meshheading:9261317-Hypersensitivity,
pubmed-meshheading:9261317-Immunosuppressive Agents,
pubmed-meshheading:9261317-Keratitis,
pubmed-meshheading:9261317-Kidney,
pubmed-meshheading:9261317-Male,
pubmed-meshheading:9261317-Middle Aged,
pubmed-meshheading:9261317-Prednisone,
pubmed-meshheading:9261317-Time Factors,
pubmed-meshheading:9261317-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Systemic cyclosporine A in severe atopic keratoconjunctivitis.
|
|
pubmed:affiliation |
Department of Ophthalmology, Hospital Bichat, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Case Reports,
Research Support, Non-U.S. Gov't
|
